Innocan Pharma Corporation CEO Iris Bincovich tells Proactive its recent study of its CBD-loaded liposome technology on dogs showed positive data after a single administration, improving dog's symptoms.
Bincovich says the group is aiming to generate more data, with the hopes to begin licensing discussions within the next 12 months.